StonvexLoading…
StonvexStonvexStonvexCore line items from CAG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-22 | Q4 2025 2025-11-23 | Q3 2025 2025-08-24 | Annual 2025 2025-05-25 |
|---|---|---|---|---|
Revenue | $8.40B | $5.61B | $2.63B | $11.61B |
Operating Income | $29.90M | $-250.20M | $347.40M | $1.36B |
Net Income | $-299.30M | $-663.60M | $164.50M | $1.15B |
EPS (Diluted) | $-0.63 | $-1.04 | $0.34 | $2.40 |
Total Assets | $19.21B | $19.54B | $21.17B | $20.93B |
Total Liabilities | $11.05B | $11.45B | $12.26B | $12.00B |
Cash & Equivalents | $55.10M | $46.60M | $698.10M | $68.00M |
Free Cash Flow OCF − CapEx | $581.40M | $112.60M | $-26.20M | $1.30B |
Shares Outstanding | 478.90M | 478.80M | 479.60M | 479.70M |